Popular on TelAve
- Grok Wrote a Direct Message to Elon Musk Discussing Netverse & Phinge CEOs Challenge to Live Debate & Added "it'd be epic to see you two hash it out"
- Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
- Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
- Assent Recognized as a Leader in First-Ever Product Compliance Green Quadrant
- Announcing the "Utsunomiya Gyoza Festival 2025" to be held November 1 and 2 in Utsunomiya City, Tochigi Pref, Japan
- Tina Glasneck Launches New Romantasy, A Dragon's Queen, Blending Dragons, Fae Courts, and Forbidden Love
- $20 Target in Noble Capital Markets Report Supported by Live Stream of 1ST Global Super League Kerala Event from AI Powered Sports Leader: $SEGG
- SPOZZ, the Community-Owned Direct-to-Fan Music Ecosystem, adds "BEATS" — a Creator-to-Creator Marketplace
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- Vesica Health Granted PLA Billing Code for AssureMDx
Global Biopsy Device Market is anticipated to surpass USD 2.8 Billion by the year end of 2025
TelAve News/10604714
Renub Research report titled "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application, Companies" captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future. Global Biopsy Device Market is anticipated to surpass USD 2.8 Billion by the year end of 2025.
Biopsy refers to surgical removal of a tissue from any human organ in order to know the existence of a particular cancer disorder. This procedure is performed by surgeons, cardiologists and radiologists. The use of each biopsy tool can vary depending on the type of organ being considered.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php
The main factor driving market growth is minimal invasive surgery which mitigates risks and side effects. In addition, increasing awareness about chronic disease diagnosis increases demand for advanced biopsy technologies such as stereotactic-guided biopsy. Nevertheless, high biopsy procedure costs and limited availability of skilled professionals in low-income countries are hampering market growth.
More on TelAve News
Biopsy was one of the main cancer disease screening methods and is commonly used in breast, hair, and prostate cancer diagnosis. According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Therefore, the market is expected to increase with the rising incidence of cancer cases and advancements in biopsy devices.
Most countries have services for early breast cancer detection. These policies will therefore increase the rate of adoption of biopsy devices and thus have a positive impact on the development of the industry of biopsy devices in the foreseeable future.
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php
Market Summary:
By Segments: The product-based demand for biopsy devices is categorized into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and kits and others. The needle-based biopsy tools gained the largest market share of biopsy products in 2018. This segment is also expected to grow at the fastest rate in the forecast period due to an increase in breast cancer, gastrointestinal tract diseases and soft tissue sarcomas.
By Application: Breast biopsy in the product segment which has produced the highest revenue in 2018 and is expected to maintain its dominance over the forecast period, according to the report. This is due to an increase in the number of patients with breast cancer who have been observed across the globe over the years and are expected to continue this trend in the future.
More on TelAve News
By Regions: Due to the high availability of trained medical professionals, the existence of well-developed infrastructure facilities and the presence of a number of key players, North America holds the largest market share in 2018 and is expected to maintain its dominance during the forecast period.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Key Topics Covered :
1. Introduction
2. Research Methodology
3. Executive Summery
4. Global – Biopsy Devices Market
5. Market Share – Global Biopsy Devices
6. By Product - Biopsy Devices Market
7. By Application - Biopsy Devices Market
8. By Region - Biopsy Devices Market
9. By End - User - Biopsy Devices Market
10. Becton, Dickinson and Company – Company Analysis
11. B. Braun Melsungen AG – Company Analysis
12. Cardinal Health, Inc. – Company Analysis
13. Olympus Corporation – Company Analysis
14. Boston Scientific Corporation – Company Analysis
15. Medtronic plc – Company Analysis
16. Hologic, Inc. – Company Analysis
17. Growth Drivers
18. Challenges
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Biopsy refers to surgical removal of a tissue from any human organ in order to know the existence of a particular cancer disorder. This procedure is performed by surgeons, cardiologists and radiologists. The use of each biopsy tool can vary depending on the type of organ being considered.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php
The main factor driving market growth is minimal invasive surgery which mitigates risks and side effects. In addition, increasing awareness about chronic disease diagnosis increases demand for advanced biopsy technologies such as stereotactic-guided biopsy. Nevertheless, high biopsy procedure costs and limited availability of skilled professionals in low-income countries are hampering market growth.
More on TelAve News
- National Compliance Firm issues Artificial Intelligence Policy Program for Mortgage Banking
- Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
- Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
- Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
- Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
Biopsy was one of the main cancer disease screening methods and is commonly used in breast, hair, and prostate cancer diagnosis. According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Therefore, the market is expected to increase with the rising incidence of cancer cases and advancements in biopsy devices.
Most countries have services for early breast cancer detection. These policies will therefore increase the rate of adoption of biopsy devices and thus have a positive impact on the development of the industry of biopsy devices in the foreseeable future.
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php
Market Summary:
By Segments: The product-based demand for biopsy devices is categorized into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and kits and others. The needle-based biopsy tools gained the largest market share of biopsy products in 2018. This segment is also expected to grow at the fastest rate in the forecast period due to an increase in breast cancer, gastrointestinal tract diseases and soft tissue sarcomas.
By Application: Breast biopsy in the product segment which has produced the highest revenue in 2018 and is expected to maintain its dominance over the forecast period, according to the report. This is due to an increase in the number of patients with breast cancer who have been observed across the globe over the years and are expected to continue this trend in the future.
More on TelAve News
- Qvarz LLC Expands Global Reach with High-Precision Quartz Cuvettes and Optical Components
- $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG)
- Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
- Arc Longevity Sells Out Debut Women's Creatine Gummy
- New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
By Regions: Due to the high availability of trained medical professionals, the existence of well-developed infrastructure facilities and the presence of a number of key players, North America holds the largest market share in 2018 and is expected to maintain its dominance during the forecast period.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Key Topics Covered :
1. Introduction
2. Research Methodology
3. Executive Summery
4. Global – Biopsy Devices Market
5. Market Share – Global Biopsy Devices
6. By Product - Biopsy Devices Market
7. By Application - Biopsy Devices Market
8. By Region - Biopsy Devices Market
9. By End - User - Biopsy Devices Market
10. Becton, Dickinson and Company – Company Analysis
11. B. Braun Melsungen AG – Company Analysis
12. Cardinal Health, Inc. – Company Analysis
13. Olympus Corporation – Company Analysis
14. Boston Scientific Corporation – Company Analysis
15. Medtronic plc – Company Analysis
16. Hologic, Inc. – Company Analysis
17. Growth Drivers
18. Challenges
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
0 Comments
Latest on TelAve News
- Launch of Professional Private Autopsy Services to Support Families, Professionals, and Researchers
- He Started a New Career at 77; Maybe Not His Last
- "The Art of Philanthropy" — A Year-Long Campaign Supporting the USO and Military Veterans
- TRUE Palliative Care Launches as California Strengthens Commitment to Compassionate Care Under SB 403
- Cell Tower AI Launches AI Platform Powered by ChatGPT to Disrupt the Cell Tower Industry
- Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses
- $73.6 Million in Order Backlog Poised for Explosive Growth in 2026; Streamlined Share Structure: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
- Osric Langevin Unveils "Quantitative Trend" Framework for Multi-Asset Analysis in Q4 2025
- Experience Days Named Among the UK's Top Christmas Gifts
- New Free Educational Bingo Cards Make Learning English Fun for First Graders
- Wzzph Provides Stablecoin Trading Solutions for Latin American Traders Amid Digital Currency Policy Adjustments
- NaturismRE Calls for Recognition of AI as Sentient Kin in Global Bill of Rights
- PDS Plumbing & Air Honors Veterans with "Free Tune-Up & A Turkey" Giveaway
- AgeImmune Announces the Launch of ImmuneG.I. — A Doctor-Formulated Herbal Supplement Supporting Gut and Digestive Wellness
- Precision Adult Care Unveils Essential Guidelines for Choosing a Senior Home Care Company
- Postmortem Pathology Delivers Expert Private Autopsy Services with Compassion and Precision
- Colorado Families Turn to Private Autopsies for Peace of Mind
- $5.4 Million Growth Acceleration, Fleet Expansion and $1.485 Million Strategic Financing: Multi Ways Holdings (N Y S E: MWG) $MWG
- Delta Capital Group Expands Business Funding Terms Up to 24 Months
- Hip-HopVibe.com Launches HHV Media Network in Partnership with The Publisher Desk